In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with part 1 of our episode with Thomas Eldered, Executive Chairman at Flerie. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Where his entrepreneurial spark originated, and how they created a CMO (before that was even a thing) after several failed plans How did the timing of his first exit and having ‘cash during...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Mamelak, Founder & President at Custom Biologics. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dan, covering: How reading The Billion-dollar Molecule book inspired him to explore a pathway into cutting-edge drug development The founding story of his company and some timeless advice not to burn bridges How the Canadian...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:  Denise Bowser from Onyx Scientific Audrey Greenberg from SK Pharmteco Kendalle Burlin O’Connell from MassBio Elisabeth Stampa from Medicines For Europe  Sabina Ouimet-Storrs from GHO Capital In this episode, we feature highlights from recent interviews with some of the most inspiring women in the life sciences industry. These women sat down with host, Raman Sehgal, to...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alastair Hay, Vice President of Peptides at Almac Sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alastair, covering: The story behind Almac’s early bet of getting into the peptide game Behind the scenes of the incredible growth journey of Almac from a few hundred to 7000+ people... and some insight into the secret sauce...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Brett Alderson, President and Site Leader of Novacina. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Brett, covering: The complexities of being on the inside of big pharma looking to carve out your site... then transitioning into a customer-facing CDMO Leaning into the freedom and liberation of having the shackles off as an...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Arvid Söderhall, CEO at Empros Pharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Arvid, covering: The personal story of a pediatrician treating an obese child that led to the creation of Empros Pharma and its lead asset The 10-year journey from an idea to a successful Phase IIb trial... and what it felt like to reach the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Sabina Ouimet-Storrs, Principal at GHO Capital Partners James West, Managing Director at Lincoln International Derek Hennecke, investor and board member in biopharma and cell therapy manufacturing Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests, covering: The year of the failed process in 2023... Which sub-segments of the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Elisabeth Stampa, President Medicines for Europe and Board Chair at Medichem.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Elisabeth, covering: She took the reigns of the family pharmaceutical firm from her father The struggle of turning around the business through rationalization and divestment and critical lessons learned...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kendalle Burlin O’Connell, CEO and President of MassBio.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kendalle, covering: The story behind how Massachusetts became one of the biggest biotech clusters in the world and why this ecosystem has such an energy Kendalle’s non-linear journey into MassBio and how she made an impact (and...

Founder of the Center for Breakthrough Medicines - now part of SK Pharmteco. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Audrey, covering: How a career in real estate financial services led her to the world of cell & gene therapy The story of the creation of the Center for Breakthrough Medicines to its eventual sale and ‘fit’ with SK Pharmteco Why Philadelphia’s 'Cellicon Valley' is becoming one of the hottest life science clusters in...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Denise Bowser, Co-Founder and Commercial Director of Onyx Scientific. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Denise, covering: The founding story of Onyx and helping the company gain traction in the early years A lesson in M&A - being acquired as a great business and being allowed to thrive as a great business The...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dominic (Nick) Marasco, Executive President and Chief Commercial Officer at Envision Pharma Group. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering: Building businesses, learning lots, and selling BioAgilytix With many options on the table... what was it that attracted him to Envision Pharma Group The real-life...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Himanshu Gadgil, CEO at Enzene Biosciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Himanshu, covering: How a personal tragedy led him from the US to India on a mission to make an impact Shifting from a technical to commercial focus to launch several biosimilars in India and beyond Being at the inception of a big pharma...

In this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023.   In the second part of our series on the top trends 2023, we dive deep into the dynamic and ever-evolving life sciences sector. From its various life cycles to the winds of change shaping the industry in 2024, there is a positive upturn on the horizon. In part two of the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Field, President & CEO of Lifesciences Ontario. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering: How the combination of his scientific background and his passion for public policy made him a perfect fit for Lifesciences Ontario (LSO) How the pandemic acted as a wake-up call and catalyst to...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Diana Kraskouskaya, co-founder and CEO of Dalriada Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Diana, covering: Exactly what ‘the Toronto paradox’ is... How two, seed-funded failures, led to identifying a gap in the market along with access to a rich talent pool The challenges and realities of starting, growing and scaling a CRO...

In this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023.   This special episode covers five key trends Raman identified including: The biotech slowdown in 2023 and how it affected the biotech sponsor space  Covid rebalancing and the macro-factors that have affected the sector  A continued focus on the life sciences supply chain -...

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey P. Kiplinger, Partner at Selling Science. Your host, Raman Sehgal, sits down with Jeff to discuss his new book, 'Expert to Entrepreneur'.  Jeff Kiplinger is a PhD chemist who, after leaving a scientific leadership role at Pfizer in 1998, transitioned to business leadership and an entrepreneurial track. In 2007 he founded Averica Discovery, an analytical drug...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Clement Fourny, SVP of Commercial at SmartLabs. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Clement, covering: His journey of exploring options and opportunities, which led him to the life sciences space at just the right time Why modular labs and manufacturing suites as a service could provide a de-risked and cost-effective...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Manuel Leal, Corporate Marketing Director at Ardena. Eden Turner, Senior Conference Producer at Informa Connect Life Sciences Catherine Hunter, Senior Commercial Manager at ramarketing   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology outsourcing events space, covering: How industry events are experiencing record numbers in a post-pandemic world The...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Bittorf, Founder and Principal Consultant of SCxCMC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kevin, covering: Joining a little company called Vertex Pharma when it was looking to be innovative The leap of faith required to become a consultant, and why helping smaller businesses makes a bigger difference An insight into...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Andi White, Head of Business Operations & Strategy for the Healthcare Industry Solutions Accelerator at Microsoft. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andi, covering: How five years at GE helped develop and shape Andi into a leader Why having a broad mindset early on in your career will help you flourish down the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Charles Ruban, CEO at Verdot. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Charles, covering: Crossing the border from supply chain to R&D, lessons learned from a technician turned business leader Creating the most extensive peanut allergy clinical trial in the world and opting for an IPO instead of a big pharma licensing...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dirk Lange, Head of Life Science Services at MilliporeSigma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, covering: What he has learned from 25 years of bouncing around geographically in terms of cultural differences in understanding clients and colleagues Life on both sides of the fence as a drug sponsor and a CDMO,...